Viewing Study NCT01235195


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2026-04-15 @ 11:25 PM
Study NCT ID: NCT01235195
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2010-11-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A0501097
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators